| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | Australia | 4 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | Canada | 3 | |
| #5 | Singapore | 2 | |
| #6 | China | 1 | |
| #7 | Hungary | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Analysing materials | |
| #5 | Climate change mitigation in goods production |
| # | Name | Total Patents |
|---|---|---|
| #1 | Andersson Tommy | 8 |
| #2 | Henriksen Dennis | 7 |
| #3 | Sjölander Anita | 4 |
| #4 | Sjolander Anita | 2 |
| #5 | Bjartell Anders | 2 |
| #6 | Tadikonda Veerabhadra Pratap | 1 |
| #7 | Ford Caroline | 1 |
| #8 | Sjoelander Anita | 1 |
| #9 | Holst Peter Johannes | 1 |
| #10 | Veerabhadra Pratap Tadikonda | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020212514A1 | Peptides in combination with immune checkpoint inhibitors for use in treatment of cancer | |
| WO2020053200A1 | Peptides for use in treatment of psoriasis | |
| EP3666789A1 | Linear solution phase routes for wnt hexapeptides | |
| CN111417403A | Role of WNT5A peptide in reducing cancer stem cells | |
| EP3613757A1 | Solution phase routes for wnt hexapeptides | |
| EP2726880A1 | Treatment of prostate cancer and a method for determining the prognosis for prostate cancer patients | |
| AU2006253056A1 | A peptide ligand to impair cancer cell migration |